Costimulation of T cells by OX40, 4-1BB, and CD27

Cytokine and Growth Factor Reviews

Volumn 14, Issue 3-4, 2003, Pages 265-273

  Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Costimulation; Ligation; T cells

Indexed keywords

CD134 ANTIGEN; CD137 ANTIGEN; CD27 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; LIGAND;

CELL DEATH; CELL MIGRATION; COMPLEX FORMATION; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE BINDING; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0038658898     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00025-X     Document Type: Review

References (90)

1. Paterson DJ, et al. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987;24(12):1281-90.
2. Gramaglia I, et al. OX40-ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998; 161(12):6510-7.
3. Strober W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 1996;183(3):979-89.
4. Gramaglia I, et al. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol 2000;653043-50.
5. Weinberg AD, et al. Target organ-specific up-regulation of the MRC OX40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J Immunol 1994;152(9):4712-21.
6. Tittle TV, et al. Expression of the T-cell activation antigen, OX40, identifies alloreactive T cells in acute graft-versus-host disease. Blood 1997;89(12):4652-8.
7. Lamb Jr LS, et al. Expression of CD134 (OX40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. Cytometry 1999;38(5):238-43.
8. Vetto JT, et al. Presence of the T-cell activation marker OX40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am J Surg 1997;174(3):258-65.
9. Brugnoni D, et al. CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis. Br J Rheumatol 1998;37(5):584-5.
10. Yoshioka T, et al. Contribution of OX40/OX40-ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol 2000;30(10):2815-23.
11. Higgins LM, et al. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40-ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40-ligand-IgG fusion protein. J Immunol 1999;162(1):486-93.
12. Stuber E, et al. The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (Celiac disease, Crohn's disease, ulcerative colitis). Eur J Clin Invest 2000;30(7):594-9.
13. Akiba H, et al. Critical contribution of OX40-ligand to T helper cell type 2 differentiation in experimental Leishmaniasis. J Exp Med 2000;191(2):375-80.
14. Jember AG, et al. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med 2001;193(3):387-92.
15. Stuber E, et al. Cross-linking of OX40-ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995;2(5):507-21.
16. Ohshima Y, et al. Epression and function of OX40-ligand on human dendritic! cells. J Immunol 1997;159(8):3838-48.
17. Murata K, et al. Impairment of antigen-presenting cell function in mice lacking expression of OX40-ligand. J Exp Med 2000;191(2):365-74.
18. Baum PR, et al. Molecular characterization of murine and human OX40/OX40-ligand systems: identification of a human OX40-ligand as the HTLV-1-regulated protein gp34. EMBO J 1994;13(17):3992-4001.
19. Takasawa N, et al. Expression of gp34 (OX40-ligand) and OX40 on human T cell clones. Jpn J Cancer Res 2001;92(4):377-82.
20. Wang HC, Klein JR. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation. J Immunol 2001;167(12):6717-23.
21. Imura A, et al. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 1996;183(5):2185-95.
22. Souza HS, et al. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40-ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999;45(6):856-63.
23. Aten J, et al. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 2000;11(8):1426-38.
24. Kwon BS, Weissman SM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci USA 1989;86(6):1963-7.
25. Pollok KE, et al. Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol 1993;150(3):771-81.
26. Schwarz H, et al. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 1995;85(4):1043-52.
27. Pollok KE, Kim SH, Kwon BS. Regulation of 4-1BB expression by cell-cell interactions and the cytokines-4. Eur J Immunol 1995;25(2):488-94.
28. Gramaglia I, et al. Costimulation of antigen-specific CD4 T cells by 4-1BB-ligand. Eur J Immunol 2000;30(2):392-402.
29. Melero I, et al. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol 1998;190(2):167-72.
30. Heinisch IV, et al. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. J Allergy Clin Immunol 2001;108(1):21-8.
31. Futagawa T, et al. Expression and function of 4-1BB and 4-1BB-ligand on murine dendritic cells. Int Immunol 2002;14(3):275-86.
32. Wang S, et al. The potential roles of 4-1BB costimulation in HIV Type I infection. AIDS Res Hum Retrovir 1998;14(3):223-31.
33. Tan JT, et al. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses. Transplantation 2000;70(1):175-83.
34. Goodwin RG, et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol 1993;23(10):2631-41.
35. Pollok KE, et al. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 1994;24(2):367-74.
36. van Lier RA, et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 1987;139(5):1589-96.
37. Bigler RD, Bushkin Y, Chiorazzi N. S152 (CD27). A modulating disulfide-linked T cell activation antigen. J Immunol 1988;141(1): 21-8.
38. Hintzen RQ, et al. Regulation of CD27 expression on subsets of mature T lymphocytes. J Immunol 1993;151(5):2426-35.
39. Gravestein LA, et al. Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Eur J Immunol 1993;23(4): 943-50.
40. Goodwin RG, et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993;73(3):447-56.
41. Hintzen RQ, et al. Characterization of the human CD27-ligand, a novel member of the TNF gene family. J Immunol 1994;152(4): 1762-73.
42. Agematsu K, et al. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 1995;25(10):2825-9.
43. Agematsu K, et al. Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J Immunol 1995;154(8):3627-35.
44. Oshima H, et al. Characterization of murine CD70 by molecular cloning and mAb. Int Immunol 1998;10(4):517-26.
45. Kopf M, et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 1999;11(6):699-708.
46. Chen AI, et al. OX40-ligand has a critical costimulatory role in dendritic cell-T cell interactions. Immunity 1999;11(6):689-98.
47. Pippig SD, et al. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J Immunol 1999;1636520-9.
48. Maxwell J, et al. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol 2000; 164107-12.
49. Brocker T, et al. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur J Immunol 1999;29(5):1610-6.
50. Walker LS, et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J Exp Med 1999;190(8):1115-22.
51. Rogers PR, et al. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001;15445-55.
52. DeBenedette MA, et al. Analysis of 4-1BB-ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL, and CD28 reveals a role for 4-1BBL in skin allograft rejection a.nd in the cytotoxic T cell response to influenza virus. J Immunol 1999;163(9):4833-41.
53. Tan JT, et al. 4-1BB-ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 1999;163(9):4859-68.
54. Tan JT, et al. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J Immunol 2000;164(5):2320-5.
55. Melero I, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997;3(6):682-5.
56. Melero I, et al. Amplification of tumor immunity by gene transfer of the costimulatory 4-1BB-ligand: synergy with the CD28 costimulatory pathway. Eur J Immunol 1998;28(3):1116-21.
57. Takahashi C, Mittler RS, Vella AT. 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 1999;162(9):5037-40.
58. Guinn BA, et al. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J Immunol 1999;162(8):5003-10.
59. Cooper D, Bansal-Pakala P, Croft M. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur J Immunol 2002;32(2):521-9.
60. Cannons JL, et al. 4-1BB-ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol 2001;167(3):1313-24.
61. Diehl L, et al. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J Immunol 2002;168(8):3755-62.
62. Bertram EM, Lau P, Watts TH. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB-ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J Immunol 2002; 168(8):3777-85.
63. Agematsu K, et al. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD. J Immunol 1994;153(4):1421-9.
64. Hintzen RQ, et al. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995;154(6):2612-23.
65. Hendriks J, et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000;1(5):433-40.
66. Arens R, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001;15(5):801-12.
67. Couderc B, et al. Enhancement of antitumor immunity by expression of CD70 (CD27-ligand) or CD154 (CD40-ligand) costimulatory molecules in tumor cells. Cancer Gene Ther 1998;5(3):163-75.
68. Lorenz MG, et al. Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L). Hum Gene Ther 1999;10(7):1095-103.
69. Kelly JM, et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 2002;3(1):83-90.
70. Gravestein LA, et al. The TNF receptor family member CD27 signals to Jun N-terminal kinase via TRAF2. Eur J Immunol 1998;28(7):2208-16.
71. Saoulli K, et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998;187(11): 1849-62.
72. Akiba H, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 1998;273(21):13353-8.
73. Kawamata S, et al. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF)2- and TRAF5-mediated NF-kappaB activation. J Biol Chem 1998;273(10):5808-14.
74. Arch RH, Thompson CB, 4-1BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol 1998;18(1):558-65.
75. Lee HW, et al. 4-1BB promotes the survival of CD8(+) T lymphocytes by increasing expression of Bcl-x(L) and Bfl-1. J Immunol 2002;169(9):4882-8.
76. Laderach D, et al. 4-1BB costimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells. Int Immunol 2002;14(10):1155-67.
77. Weinberg AD, et al. Engagement of the OX40 receptor in vivo enhances antitumor immunity. J Immunol 2000;164(4):2160-9.
78. Kjaergaard J, et al. Therapeutic efficacy of OX40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res 2000;60(19):5514-21.
79. Bansal-Pakala P, Croft M. Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137). J Immunol 2002;169(9):5005-9.
80. Blazar BR, et al. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J Immunol 2001;166 (5):3174-83.
81. De Smedt T, et al. OX40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol 2002;168(2):661-70.
82. Ohshima Y, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naïve human CD4(+) T cells into high IL-4-producing effectors. Blood 1998;92(9):3338-45.
83. Flynn S, et al. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40-ligand, instructs CD4 T cells to express interleukin-4 and upregulates expression of the chemokine receptor, blr-1. J Exp Med 1998;188(2):297-304.
84. Weinberg AD, et al. Blocking OX40/OX40-ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J Immunol 1999;162(3):1818-26.
85. Ndhlovu LC, et al. Critical involvement of OX40-ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 2001;167(5):2991-9.
86. Malmstrom V, et al. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol 2001;166(11):6972-81.
87. Kim YJ, et al. Human 4-1BB regulates CD28 costimulation to promote Th1 cell responses. Eur J Immunol 1998;28(3): 881-90.
88. Kobata T, et al. CD27 is a signal-transducing molecule involved in CD45RA+ naïve T cell costimulation. J Immunol 1994;153(12): 5422-32.
89. Lens SM, et al. Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells. Immunology 1997;90(1):38-45.
90. Lens SM, et al. Phenotype and function of human B cells expressing CD70 (CD27-ligand). Eur J Immunol 1996;26(12):2964-71.